Chiropractors in West Jefferson, NC Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. April Hall Taylor, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 303 C East Second St, West Jefferson, NC 28694 Phone: 336-846-2225 Fax: 336-846-1117 |
 Current Chiropractic Clinic, Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 936 Highway 221 Business, West Jefferson, NC 28694 Phone: 336-846-5651 Fax: 336-846-6401 |
Ashe Chiropractic, Inc. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 303 C East Second St, West Jefferson, NC 28643 Phone: 336-846-2225 Fax: 336-846-1117 |
 Dr. Cameron S Current, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 936 Highway 221 Business, West Jefferson, NC 28694 Phone: 336-846-5651 Fax: 336-846-6401 |
News Archive
Urban environment with high levels of air pollution associated with childhood obesity risk
Children living in urban areas with high levels of air pollution, noise and traffic may be at higher risk of childhood obesity, according to a study by the Barcelona Institute for Global Health (ISGlobal)-a centre supported by the "la Caixa" Foundation-and the University Institute for Primary Care Research Jordi Gol (IDIAP Jordi Gol). The study was funded by the La Marató de TV3 Foundation.
Positive clinical data from Phase II study of elacytarabine in patients with AML reported
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
Kolltan Pharmaceuticals announces treatment of first cancer patient with KTN3379
Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced treatment of the first cancer patient with Kolltan's lead drug candidate, KTN3379, as part of a Phase 1 clinical study evaluating safety, preliminary evidence of antitumor activity, and pharmacokinetics. KTN3379 is a human monoclonal antibody that blocks the activity of ErbB3, a member of the ErbB family of receptor tyrosine kinases.
New book can change the way cancer is detected
Jenny Hrbacek's new book, Cancer Free! Are You SURE? can play a role in changing the way cancer is detected. It contains lifesaving information. Far too many people – and she was one of them – get a diagnosis out of the blue and are whisked to the operating table or chemotherapy chair in a matter of days.
PharmAthene receives clinical hold order from FDA for SparVax rPA anthrax vaccine program
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today it has received notification from the U.S. Food and Drug Administration (FDA) that its SparVax rPA anthrax vaccine program has been placed on clinical hold.
› Verified 7 days ago
Chiropractors
Optometrists
Physical Therapists
Speech-Language Pathologists
Occupational Therapists